Micro-RNA Expression Profiles in High Risk Prostate Cancer

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01220427

Enrollment

300

Registered

2010-10-13

Start date

2007-06-30

Completion date

Unknown

Last updated

2016-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer, Radical Prostatectomy

Keywords

high-risk prostate cancer, radical prostatectomy, micro-RNA

Brief summary

The purpose of this study is to determine whether specific Micro-RNA expression profiles are related to Prostate cancer outcome.

Interventions

None listed

Study design

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

MALE

Age

35 Years to 80 Years

Healthy volunteers

Inclusion criteria

Patients with clinically localised high risk prostate cancer (cT\>2, bx GS \>7, PSA \>20 ng/ml) scheduled for radical prostatectomy.

Exclusion criteria

Non high risk prostate cancer

Design outcomes

Primary

Measure	Time frame	Description
Recurrence free survival	Yearly update until clinical progression	The patients will be followed in regular time intervals in accordance with the EAU-Guidelines (2010) and the S-3 Guideline for Prostate cancer of the German Urological Association. Data will be updated once yearly for until death.

Secondary

Measure	Time frame	Description
Cancer specific survival	Yearly update until death	The patients will be followed in regular time intervals in accordance with the EAU-Guidelines (2010) and the S-3 Guideline for Prostate cancer of the German Urological Association. Data will be updated once yearly until death.

Countries

Germany

Outcome results